A comparative study between nifedipine and isoxsuprine in the suppression of preterm labor pain

Authors

  • Susheela Khoiwal Department of Obstetrics and Gynecology, RNT Medical College, Udaipur, Rajasthan, India
  • Vandana Patidar Department of Obstetrics and Gynecology, RNT Medical College, Udaipur, Rajasthan, India
  • Radha Rastogi Department of Obstetrics and Gynecology, RNT Medical College, Udaipur, Rajasthan, India
  • Bharat Tailor Department of Obstetrics and Gynecology, RNT Medical College, Udaipur, Rajasthan, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20202727

Keywords:

Isoxsuprine, Nifedipine, Preterm labor pain, Tocolytic drug

Abstract

Background: A prospective study was conducted to compare the effectiveness of Nifedipine and Isoxsuprine in suppression of preterm labour pain as tocolytics drug. As preterm labour pain is major contributor for perinatal morbidity and mortality. The aims of this study were to assess the effect of nifedipine and isoxsuprine in threatened preterm labour with the aim of preventing preterm birth and its sequelae.

Methods: This study was conducted on 100 patients coming to Pannadhay Rajkiya Mahila Chikitsalaya, RNT Medical College, Udaipur and attending OPD and IPD with complain of uterine contractions between 28-36 weeks of gestation.

Results: Nifedipine was more effective than isoxsuprine hydrochloride as tocolytic agent.

Conclusions: There is high incidence of preterm labour in India which leads to neonatal morbidity and mortality. Nifedipine is a better tocolytic drug compared to isoxsuprine hydrochloride.

References

Martin JA, Kochanek KD, Strobino DM, Guyer B, MacDorman MF. Annual summary of vital statistics-2003. Pediatr. 2005;115(3):619-34.

Begum F, Buckshee K, Pande JN. Risk factors associated with preterm labor. Bangladesh Med Ras Coune Bull. 2003;29:59-66.

Mishra R. Practical obstetricpProblems. In: Ian Donald 7th edition Chapter 21; 2016:409.

Goldenberg Rl, Chehane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84.

ACOG technical bulletin. Preterm labor. Number 206-June 1995 (Replaces No. 133, October 1989). Int J Gynaecol Obstet. 1995;50(3):303-13.

Lyell DJ, Pullen KM, Mannan J, Chitkara U, Druzin ML, Caughey AB, et al. Maintenance Nifedipine Tocolysis compared with Placebo. Obstel Gynecol. 2008;112:1221-6.

Waheed A, Shami N. Preterm labour effectiveness of transdermal glyceryltrinitrate patch. Professional Med J. 2011;18(2):174-80.

Royal College of Obstetrics and Gynaecologists. Tocolysis for women in preterm labour. Green-top Guideline. February 2011. No. 1b. Available at: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/ gtg1b/. Accessed on 28th March 2020.

Rayamajhi R, Pratap K. A comparative study between nifedipine and isoxsuprine in the suppression of preterm labour, Kathmandu Univ Med J. 2003;1(2):85-90.

King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour (Cochrane Review). The Cochrane Library; 2004:3.

Smith CS, Woodland MB. Clinical comparison of oral nifedipine and subcutaneous terbutaline for initial tocolysis. Am J Perinatol. 1993;10:280-4.

Singh N, Singh U, Seth S. Comparative study of Nifedipine and isoxsuprine as tocolytics for preterm labour. The J Obstet Gynecol India. 2011;61(5):512-5.

Singh S, Gupta K, Ahluwalia G. Role of nifedipine in preterm labour and its effect on perinatal outcome. J Obstet Gynecol India 1992;687-693.

London: RCOG Press. Clinical guideline no. I (B): Tocolytic drugs for women in preterm labor. 2002. Available at: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/ gtg1b/. Accessed on 28th March 2020.

Downloads

Published

2020-06-25

Issue

Section

Original Research Articles